Phoenix Biotech Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
For the six months, net loss was USD 1.92 million compared to USD 0.489566 million a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.16 USD | 0.00% | -10.77% | -89.45% |
Apr. 02 | CERo Therapeutics Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 11 | Top Premarket Decliners | MT |
1st Jan change | Capi. | |
---|---|---|
-89.45% | 17.08M | |
+4.02% | 111B | |
+11.47% | 105B | |
-12.66% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.07% | 16.96B | |
+2.55% | 13.7B | |
+35.94% | 12.45B |